ProQR Therapeutics NV (NASDAQ:PRQR)

0.8181
Delayed Data
As of 3:57pm ET
 -0.008 / -0.97%
Today’s Change
0.53
Today|||52-Week Range
9.09
-89.79%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 1.23, with a high estimate of 3.94 and a low estimate of 0.78. The median estimate represents a +50.78% increase from the last price of 0.82.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in ProQR Therapeutics NV. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.21
Sales
$839.0K
Reporting Date
Nov 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.05%
 
 
 
 
 
 
Growthannually 14.48%
 
 
 
 
 
 

Sales

Growthquarterly -18.15%
 
 
 
 
 
 
Growthannually 191.51%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.